Healthcare / Medical Care FacilitiesNYSE
$191.03
+1.23 (+0.65%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.5B · quality 84.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
58/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$12.3B
P/E
18.4x
↓EV/EBITDA
10.1x
↓ROE
-114.7%
↓Gross Margin
32.2%
↓Debt/Equity
-19.77
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2007–2025 · 18 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
+8.4%
FCF margin
9.6%
FCF / Net income
1.75x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $13.64B · net income $746.8M · FCF $1.31B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||||
| Revenue | $13.64B | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | — | — | — | — | — | — | — | — | — |
| Net Income | $746.8M | $746.8M | $936.3M | $691.5M | $560.4M | $978.5M | $773.6M | $811.0M | $159.4M | $663.6M | $879.9M | $269.7M | $723.1M | $633.4M | $536.0M | $478.0M | $405.7M | $422.7M | $374.2M | $381.8M |
| EBITDA | $2.64B | $2.64B | $2.72B | $2.32B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.52B | $1.58B | $2.24B | $1.92B | $1.60B | $1.40B | $1.21B | $1.15B | $1.07B | $1.10B |
| EPS | 9.84 | 9.84 | 10.73 | 7.42 | 5.85 | 8.90 | 6.31 | 5.27 | 0.92 | 3.47 | 4.29 | 1.25 | 3.33 | 2.95 | 2.74 | 2.48 | 1.97 | 2.03 | 1.76 | 1.77 |
| Gross Margin | 32.2% | 32.2% | 32.9% | 31.5% | 29.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 14.7% | 14.7% | 15.3% | 13.2% | 11.3% | 15.5% | 14.7% | 14.4% | 13.4% | 16.7% | 19.0% | — | — | — | — | — | — | — | — | — |
| Net Margin | 5.5% | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | 6.1% | 8.2% | — | — | — | — | — | — | — | — | — |
| Balance Sheet | ||||||||||||||||||||
| Debt/Equity | -19.77 | -19.77 | 99.63 | 10.53 | 16.60 | — | — | — | — | — | — | — | 1.64 | 1.90 | 2.27 | 2.06 | 2.14 | 1.65 | 2.05 | — |
| Current Ratio | 1.42 | 1.42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||||
| Free Cash Flow | $1.31B | $1.31B | $1.47B | $1.49B | $961.1M | $1.29B | $1.30B | $1.31B | $784.5M | $1.01B | $1.14B | $849.2M | $818.1M | $1.16B | $550.7M | $779.9M | $566.1M | $392.1M | $295.7M | $308.9M |
| Returns | ||||||||||||||||||||
| ROE | -114.7% | -114.7% | 773.1% | 65.5% | 78.7% | 129.5% | 55.9% | 38.0% | 4.3% | 14.1% | 18.9% | 5.5% | 14.0% | 14.3% | 14.2% | 22.3% | 20.5% | 19.8% | 21.2% | — |
| Valuation | ||||||||||||||||||||
| P/E | 18.40 | 18.40 | 14.24 | 14.45 | 13.85 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 10.10 | 10.10 | 9.03 | 8.93 | 9.41 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | — | — | 110.11 | 9.46 | 10.90 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||||
| Revenue Growth | 6.5% | 6.5% | 5.6% | 4.6% | — | 0.6% | 1.4% | -0.1% | 4.9% | 1.6% | — | — | — | — | — | — | — | — | — | — |
| EPS Growth | -8.3% | -8.3% | 44.6% | 26.8% | — | 41.0% | 19.7% | 472.8% | -73.5% | -19.1% | 243.2% | -62.5% | 12.9% | 7.7% | 10.5% | 25.9% | -3.0% | 15.0% | -0.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
19.9%
EPS terminal req.
$16.95
Spread vs growth
-28.2%
5Y implied EPS CAGR
15.8%
EPS terminal req.
$20.51
Spread vs growth
-24.1%
10Y implied EPS CAGR
12.9%
EPS terminal req.
$33.03
Spread vs growth
-21.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+42.1%
Start / end P/E
12.5x → 19.4x
EPS bridge
10.73 → 9.84
Residual
-4.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.